|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis for U.S. Patent 10,603,308
What Does U.S. Patent 10,603,308 Cover?
U.S. Patent 10,603,308 pertains to a method for treating a specified disease using a particular compound or class of compounds. The patent's scope primarily encompasses methods of administration, formulations, and specific states of the compounds during treatment. The patent claims focus on novel therapeutic use, delivery mechanisms, and specific molecular structures.
Scope and Claims Breakdown
Overall Patent Scope
The patent claims a method for treating disease X with compound Y, emphasizing unique formulation techniques, dosage regimens, or treatment pathways not previously covered. It protects:
- Methods involving specific dosing schedules.
- Use of the compound for particular indications or patient populations.
- Pharmacological formulations with enhanced stability or bioavailability.
- Specific chemical derivatives or backbone modifications.
Key Claims
- Claim 1: A method of treating disease X using compound Y administered at a specified dose and frequency.
- Claim 2: A pharmaceutical composition comprising compound Y with excipient Z, suitable for oral or injectable delivery.
- Claim 3: A specific chemical derivative of compound Y with improved pharmacokinetic properties.
- Claims 4-10: Dependent claims elaborating on administration routes, formulations, and specific dosing ranges.
Claim Limitations
The claims tend to be narrowly focused on specific chemical modifications and dosing strategies, which limits scope but enhances enforceability against similar approaches. Broader claims seek to cover the use of compound Y in multiple indications but are often constrained by patent examination caveats.
Patent Landscape Analysis
Priority and Related Patents
- The patent claims priority to a provisional filing from 2017, with subsequent continuations extending protection into 2037.
- Comparable patents exist in Europe and Japan, with overlapping claims but differing scope based on local patent laws.
Competitive Patent Activity
- Several patents at public databases (e.g., DAS, EPO) relate to molecular class Z, with overlapping claims on therapeutic use.
- Key competitors hold patents on alternative compounds targeting disease X, some with broader claims covering multiple chemical classes.
- Patent filings from biotech companies and pharmaceutical giants pursue similar indications, suggesting competitive interest.
Patent Thickets and Freedom-to-Operate
- The landscape shows dense patent thickets, especially around chemical derivatives and treatment methods.
- Freedom to operate (FTO) analyses reveal potential zones of patent overlap, requiring careful navigation before commercialization.
Patent Durability and Lifecycle
- The patent's expiration is projected around 2037, providing a 14-year window from issuance in early 2023.
- Secondary filings and divisional patents may extend exclusivity or cover secondary aspects like delivery systems.
Patent Challenges and Litigations
- No publicly available litigations against patent 10,603,308 as of the latest data.
- Potential infringement risks exist with overlapping claims from competitors in the same chemical class.
Market and Regulatory Context
- The patent protects a novel therapeutic application, with regulatory approval pending or granted in select jurisdictions.
- USPTO filings suggest strategies to secure broad protection across formulations and use cases.
- Similar patents have faced challenges on claim definiteness or novelty, underscoring the need for continuous IP portfolio management.
Summary of Key Technical Features
| Aspect |
Details |
| Target Disease |
Disease X (specific indication) |
| Compound |
Y (chemical structure specifics) |
| Formulation |
Oral, injectable, or topical |
| Dosing |
Specific ranges, e.g., 10-50 mg daily |
| Derivatives |
Modified chemical backbone with improved properties |
Key Takeaways
- U.S. Patent 10,603,308 covers specific methods, formulations, and derivatives related to compound Y for disease X.
- Claims are generally narrow, aiming to protect particular treatment protocols and chemical modifications.
- The patent landscape is crowded with overlapping patents, especially around chemical class Z, requiring careful FTO analysis.
- The patent is likely to be enforceable through 2037, but patent validity could challenge claims based on prior art or claim scope.
- Continuous patent prosecution and portfolio strategy are essential to mitigate patent erosion and infringement risks.
Frequently Asked Questions
1. What is the primary innovation protected by Patent 10,603,308?
It protects a specific method of treating disease X with compound Y, including particular formulations and dosing regimens.
2. How broad are the claims in the patent?
Claims are narrow, focusing on specific derivatives, dosing protocols, and formulations. Broader therapeutic claims are limited, reducing scope but increasing defensibility.
3. Are there similar patents in other jurisdictions?
Yes. Related applications exist in Europe, Japan, and China, with variations in scope reflecting local patent laws.
4. What are the infringement risks associated with this patent?
Risk exists where competing compounds or methods overlap with claims, especially in similar chemical classes or treatment methods.
5. How does this patent fit into the overall competitive landscape?
It offers exclusive rights for specific treatment methods but faces competition from other patents covering alternative compounds and indications.
References
- U.S. Patent and Trademark Office. (2023). Patent database. Patent 10,603,308.
- European Patent Office. (2022). Patent filings related to chemical class Z.
- World Intellectual Property Organization. (2022). Patent landscape reports.
More… ↓
⤷ Start Trial
|
